- Home
- ZLAB vs VSAT Comparison
ZLAB vs VSAT Comparison
Compare ZLAB & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- VSAT
- Stock Information
- Founded
- ZLAB 2013
- VSAT 1986
- Country
- ZLAB China
- VSAT United States
- Employees
- ZLAB N/A
- VSAT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- VSAT Radio And Television Broadcasting And Communications Equipment
- Sector
- ZLAB Health Care
- VSAT Technology
- Exchange
- ZLAB Nasdaq
- VSAT Nasdaq
- Market Cap
- ZLAB 3.6B
- VSAT 1.2B
- IPO Year
- ZLAB 2017
- VSAT 1996
- Fundamental
- Price
- ZLAB $36.40
- VSAT $16.28
- Analyst Decision
- ZLAB Buy
- VSAT Buy
- Analyst Count
- ZLAB 5
- VSAT 7
- Target Price
- ZLAB $54.28
- VSAT $20.00
- AVG Volume (30 Days)
- ZLAB 886.5K
- VSAT 5.0M
- Earning Date
- ZLAB 08-05-2025
- VSAT 08-06-2025
- Dividend Yield
- ZLAB N/A
- VSAT N/A
- EPS Growth
- ZLAB N/A
- VSAT N/A
- EPS
- ZLAB N/A
- VSAT N/A
- Revenue
- ZLAB $418,326,000.00
- VSAT $4,519,571,000.00
- Revenue This Year
- ZLAB $44.07
- VSAT $4.46
- Revenue Next Year
- ZLAB $49.13
- VSAT $3.58
- P/E Ratio
- ZLAB N/A
- VSAT N/A
- Revenue Growth
- ZLAB 43.72
- VSAT 5.50
- 52 Week Low
- ZLAB $16.01
- VSAT $6.69
- 52 Week High
- ZLAB $44.34
- VSAT $26.70
- Technical
- Relative Strength Index (RSI)
- ZLAB 52.67
- VSAT 85.45
- Support Level
- ZLAB $34.79
- VSAT $14.31
- Resistance Level
- ZLAB $36.73
- VSAT $14.76
- Average True Range (ATR)
- ZLAB 1.23
- VSAT 0.90
- MACD
- ZLAB -0.46
- VSAT 0.26
- Stochastic Oscillator
- ZLAB 25.91
- VSAT 95.09
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About VSAT ViaSat Inc.
Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.